Immunology Experts

Raghuram (ram) Selvaraju

Chairman of the Board
Cellular Immunology and Molecular Neuroscience
Relief Therapeutics


 Dr. Raghuram Selvaraju born in 1978, a Swiss Citizen, also known as Ram, Ph.D., MBA is a Managing Director and Senior Healthcare Analyst in Rodman & Renshaw’s Equity Research Division. Dr. Selvaraju rejoined the firm. Earlier, he started his sell-side research analyst career with the firm in 2005. Prior to rejoining, he was a Managing Director and Senior Healthcare Analyst at MLV & Co LLC, Research Division. Prior to this, Dr. Selvaraju served as Managing Director and Head of Healthcare Equity Research at Aegis Capital Corporation, Research Division since March 2012. Before that, he served as a Senior Vice President in Equity Research and Senior Biotechnology Analyst at Morgan Joseph TriArtisan LLC, Research Division since May 2011. From 2010 to March 2011, Dr. Selvaraju served as a Senior Equity Research Analyst covering the biotechnology and pharmaceuticals sectors at Noble Financial Group, Inc., Research Division. From 2009 to 2010, he served as the Senior Vice President and Head of Healthcare Equity Research at Hapoalim Securities USA, Inc., Research Division, covering biotechnology, specialty pharmaceuticals, molecular analytics, and diagnostics. Prior to research, he started his career at the Serono Pharmaceutical Research Institute in 2000. Dr. Selvaraju served as a Technician and Pharmaceutical Researcher at the firm until 2004. Dr. Selvaraju is widely quoted in national publications such as Barron’s and The Wall Street Journal, as well as healthcare industry publications such as The Pink Sheet, BioWorld Today, and BioCentury, and has appeared numerous times on Bloomberg, CNBC, Business News Network and BTV to comment on drug development trends, healthcare reform policy, and pharma and biotech M&A. While at Serono Pharmaceutical Research Institute, Dr. Selvaraju became the youngest-ever recipient of the Serono Pharmaceutical Research Institute’s Inventorship Award for exceptional innovation and creativity in 2003. Dr. Selvaraju graduated in 1999 with a Bachelor of Science in Biological Sciences and Technical Writing from Carnegie Mellon University, a Ph.D. in Cellular Immunology and Molecular Neuroscience in 2004, a Master’s of Science in Molecular Biology from the University of Geneva in Switzerland in 2001 on the basis of his drug development research, and an M.B.A. from Cornell University’s accelerated one-year program for scientists and engineers in 2005.

Research Interest

 Cellular Immunology and Molecular Neuroscience

Global Experts from Switzerland

Global Experts in Subject